ĀÜĄņĀŅĀ×

David S. Joseph is the President & CEO at Avisa Diagnostics. He has more than 40 years of experience commercializing Medtech/pharma. David is also the Co-founder of 4 companies with successful exits (IPO, M&A). He has multiple past and present board positions. Previously, he was Chairman and CEO of Othera Pharmaceuticals (2003ā€2010), a specialty pharmaceutical company focused on treatments for ophthalmic diseases.

Prior to entrepreneurial career, David has over 15 years of executive healthcare management experience. His past and present board appointments include two successful acquisitions: Animas Corporation, a diabetes insulin pump technology acquired by Johnson & Johnson for approximately US$515 million in 2006; Morphotek, a privately held biotechnology company acquired by Eisai Pharmaceuticals for approximately US$325 million in 2007; and Allevi, a 3D Bioprinting company.

David earned his MBA in Healthcare Administration from Xavier University and received a BA in Business Administration from Kings College.